MEDVIA signs Collaborative Alliance Member agreement with PwC

MEDVIA has signed a Collaborative Alliance Member agreement with PwC, making the firm a Cultivate+ member. The contract will see the pair working together to organize sessions that fulfill the goals of both organizations

MEDVIA’s Collaborative Alliance Member agreements create official partnerships with service providers. MEDVIA has now signed the agreement with PricewaterhouseCoopers Belgium (PwC Belgium), making the firm a Cultivate+ member.

Legal entities that have a specific specialization, expertise and knowledge that is of service to our members have the possibility to become a Cultivate+ member and take part in the Collaborative Alliance program.

Cultivate+ members work with MEDVIA to provide specific expertise and organize sessions valuable to our members. They also have the opportunity to host booths at MEDVIA events, attend the CEO Roundtable and can be involved in delivering input for strategically relevant topics.

Link with general hospitals

“We are delighted to welcome PwC Belgium to the MEDVIA ecosystem,” says MEDVIA CEO Ann Van Gysel. “They offer expertise that aligns perfectly with MEDVIA’s Strategic Initiatives. In addition, their ongoing collaboration with Flanders’ general hospitals and related organizations will support us in our mission to connect our members’ innovations with hospitals, a key focus for MEDVIA over the next two years.”

PwC Belgium offers audit, tax and consulting services to a range of sectors, including pharmaceuticals, life sciences and medtech. With a comprehensive expert network in the health industry, the firm collaborates with policymakers and payers as well as pharma and device manufacturers at regional, national and international levels.

“At PwC, we work with our clients to solve complex problems,” says Jan Debaere, partner and Health Industries Lead at PwC Belgium. “By joining forces with MEDVIA, we want to move the needle on key challenges in healthcare such as digital health, value-based healthcare and advanced therapies. We look forward to shaping the future of healthcare with MEDVIA and its entire ecosystem.”